ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Isocitrate Dehydrogenase Inhibitors Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-20V5939
Home | Market Reports | Science| Biological Sciences
Global Isocitrate Dehydrogenase Inhibitors Market Insights Forecast to 2028
BUY CHAPTERS

Global Isocitrate Dehydrogenase Inhibitors Market Insights, Forecast to 2030

Code: QYRE-Auto-20V5939
Report
December 2024
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Agios
Aslan Pharmaceuticals
Bayer
BeiGene Ltd
Bristol–Myers Squibb
Celgene
Daiichi Sankyo
Philogen
Tesaro
Tragara/Adastra
Tocagen

Isocitrate Dehydrogenase Inhibitors Market

Isocitrate dehydrogenase (IDH) (EC 1.1.1.42) and (EC 1.1.1.41) is an enzyme that catalyzes the oxidative decarboxylation of isocitrate, producing alpha-ketoglutarate (α-ketoglutarate) and CO2.
Market Analysis and Insights: Global Isocitrate Dehydrogenase Inhibitors Market
The global Isocitrate Dehydrogenase Inhibitors market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Specific mutations in the isocitrate dehydrogenase gene IDH1 have been found in several brain tumors including astrocytoma, oligodendroglioma and glioblastoma multiforme, with mutations found in nearly all cases of secondary glioblastomas, which develop from lower-grade gliomas, but rarely in primary high-grade glioblastoma multiforme.Patients whose tumor had an IDH1 mutation had longer survival. Furthermore, mutations of IDH2 and IDH1 were found in up to 20% of cytogenetically normal acute myeloid leukemia (AML).These mutations are known to produce (D)-2-hydroxyglutarate from alpha-ketoglutarate.(D)-2-hydroxyglutarate accumulates to very high concentrations which inhibits the function of enzymes that are dependent on alpha-ketoglutarate.This leads to a hypermethylated state of DNA and histones, which results in different gene expression that can activate oncogenes and inactivate tumor-suppressor genes. Ultimately, this may lead to the types of cancer described above.Isocitrate dehydrogenase inhibition technology can be effectively applied to the cancer market.
Report Covers:
This report presents an overview of global market for Isocitrate Dehydrogenase Inhibitors market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Isocitrate Dehydrogenase Inhibitors, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Isocitrate Dehydrogenase Inhibitors, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Isocitrate Dehydrogenase Inhibitors revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Isocitrate Dehydrogenase Inhibitors market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Isocitrate Dehydrogenase Inhibitors revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Isocitrate Dehydrogenase Inhibitors Market Report

Report Metric Details
Report Name Isocitrate Dehydrogenase Inhibitors Market
Segment by Type
  • IDH1 Mutant Medullary Malignant Tumor
  • IDH2 Mutant Medullary Malignant Tumor
  • Others
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AGIOS, Aslan Pharmaceuticals, Bayer, Beigene, Bristol-Myers Squibb, Celgene, Daiichi Sankyo, Philogen S.p.A., Tesaro, Tragara/Adastra, Tocagen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Isocitrate Dehydrogenase Inhibitors in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Isocitrate Dehydrogenase Inhibitors companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Isocitrate Dehydrogenase Inhibitors revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Isocitrate Dehydrogenase Inhibitors Market report?

Ans: The main players in the Isocitrate Dehydrogenase Inhibitors Market are AGIOS, Aslan Pharmaceuticals, Bayer, Beigene, Bristol-Myers Squibb, Celgene, Daiichi Sankyo, Philogen S.p.A., Tesaro, Tragara/Adastra, Tocagen

What are the Application segmentation covered in the Isocitrate Dehydrogenase Inhibitors Market report?

Ans: The Applications covered in the Isocitrate Dehydrogenase Inhibitors Market report are DH Inhibitor, FLT3 Inhibitor, Hedgehog Pathway Inhibitor, Others

What are the Type segmentation covered in the Isocitrate Dehydrogenase Inhibitors Market report?

Ans: The Types covered in the Isocitrate Dehydrogenase Inhibitors Market report are IDH1 Mutant Medullary Malignant Tumor, IDH2 Mutant Medullary Malignant Tumor, Others

Recommended Reports

Cancer Therapeutics

Inhibitors & Enzymes

Diagnostics & Related

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Isocitrate Dehydrogenase Inhibitors Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 IDH1 Mutant Medullary Malignant Tumor
1.2.3 IDH2 Mutant Medullary Malignant Tumor
1.2.4 Others
1.3 Market by Application
1.3.1 Global Isocitrate Dehydrogenase Inhibitors Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 DH Inhibitor
1.3.3 FLT3 Inhibitor
1.3.4 Hedgehog Pathway Inhibitor
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Isocitrate Dehydrogenase Inhibitors Market Perspective (2019-2030)
2.2 Global Isocitrate Dehydrogenase Inhibitors Growth Trends by Region
2.2.1 Isocitrate Dehydrogenase Inhibitors Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Isocitrate Dehydrogenase Inhibitors Historic Market Size by Region (2019-2024)
2.2.3 Isocitrate Dehydrogenase Inhibitors Forecasted Market Size by Region (2025-2030)
2.3 Isocitrate Dehydrogenase Inhibitors Market Dynamics
2.3.1 Isocitrate Dehydrogenase Inhibitors Industry Trends
2.3.2 Isocitrate Dehydrogenase Inhibitors Market Drivers
2.3.3 Isocitrate Dehydrogenase Inhibitors Market Challenges
2.3.4 Isocitrate Dehydrogenase Inhibitors Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Isocitrate Dehydrogenase Inhibitors by Players
3.1.1 Global Isocitrate Dehydrogenase Inhibitors Revenue by Players (2019-2024)
3.1.2 Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Players (2019-2024)
3.2 Global Isocitrate Dehydrogenase Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Isocitrate Dehydrogenase Inhibitors, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Isocitrate Dehydrogenase Inhibitors Market Concentration Ratio
3.4.1 Global Isocitrate Dehydrogenase Inhibitors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Isocitrate Dehydrogenase Inhibitors Revenue in 2023
3.5 Global Key Players of Isocitrate Dehydrogenase Inhibitors Head office and Area Served
3.6 Global Key Players of Isocitrate Dehydrogenase Inhibitors, Product and Application
3.7 Global Key Players of Isocitrate Dehydrogenase Inhibitors, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Isocitrate Dehydrogenase Inhibitors Breakdown Data by Type
4.1 Global Isocitrate Dehydrogenase Inhibitors Historic Market Size by Type (2019-2024)
4.2 Global Isocitrate Dehydrogenase Inhibitors Forecasted Market Size by Type (2025-2030)
5 Isocitrate Dehydrogenase Inhibitors Breakdown Data by Application
5.1 Global Isocitrate Dehydrogenase Inhibitors Historic Market Size by Application (2019-2024)
5.2 Global Isocitrate Dehydrogenase Inhibitors Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Isocitrate Dehydrogenase Inhibitors Market Size (2019-2030)
6.2 North America Isocitrate Dehydrogenase Inhibitors Market Size by Type
6.2.1 North America Isocitrate Dehydrogenase Inhibitors Market Size by Type (2019-2024)
6.2.2 North America Isocitrate Dehydrogenase Inhibitors Market Size by Type (2025-2030)
6.2.3 North America Isocitrate Dehydrogenase Inhibitors Market Share by Type (2019-2030)
6.3 North America Isocitrate Dehydrogenase Inhibitors Market Size by Application
6.3.1 North America Isocitrate Dehydrogenase Inhibitors Market Size by Application (2019-2024)
6.3.2 North America Isocitrate Dehydrogenase Inhibitors Market Size by Application (2025-2030)
6.3.3 North America Isocitrate Dehydrogenase Inhibitors Market Share by Application (2019-2030)
6.4 North America Isocitrate Dehydrogenase Inhibitors Market Size by Country
6.4.1 North America Isocitrate Dehydrogenase Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Isocitrate Dehydrogenase Inhibitors Market Size by Country (2019-2024)
6.4.3 North America Isocitrate Dehydrogenase Inhibitors Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Isocitrate Dehydrogenase Inhibitors Market Size (2019-2030)
7.2 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Type
7.2.1 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Type (2019-2024)
7.2.2 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Type (2025-2030)
7.2.3 Europe Isocitrate Dehydrogenase Inhibitors Market Share by Type (2019-2030)
7.3 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Application
7.3.1 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Application (2019-2024)
7.3.2 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Application (2025-2030)
7.3.3 Europe Isocitrate Dehydrogenase Inhibitors Market Share by Application (2019-2030)
7.4 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Country
7.4.1 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Country (2019-2024)
7.4.3 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Isocitrate Dehydrogenase Inhibitors Market Size (2019-2030)
8.2 China Isocitrate Dehydrogenase Inhibitors Market Size by Type
8.2.1 China Isocitrate Dehydrogenase Inhibitors Market Size by Type (2019-2024)
8.2.2 China Isocitrate Dehydrogenase Inhibitors Market Size by Type (2025-2030)
8.2.3 China Isocitrate Dehydrogenase Inhibitors Market Share by Type (2019-2030)
8.3 China Isocitrate Dehydrogenase Inhibitors Market Size by Application
8.3.1 China Isocitrate Dehydrogenase Inhibitors Market Size by Application (2019-2024)
8.3.2 China Isocitrate Dehydrogenase Inhibitors Market Size by Application (2025-2030)
8.3.3 China Isocitrate Dehydrogenase Inhibitors Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Isocitrate Dehydrogenase Inhibitors Market Size (2019-2030)
9.2 Asia Isocitrate Dehydrogenase Inhibitors Market Size by Type
9.2.1 Asia Isocitrate Dehydrogenase Inhibitors Market Size by Type (2019-2024)
9.2.2 Asia Isocitrate Dehydrogenase Inhibitors Market Size by Type (2025-2030)
9.2.3 Asia Isocitrate Dehydrogenase Inhibitors Market Share by Type (2019-2030)
9.3 Asia Isocitrate Dehydrogenase Inhibitors Market Size by Application
9.3.1 Asia Isocitrate Dehydrogenase Inhibitors Market Size by Application (2019-2024)
9.3.2 Asia Isocitrate Dehydrogenase Inhibitors Market Size by Application (2025-2030)
9.3.3 Asia Isocitrate Dehydrogenase Inhibitors Market Share by Application (2019-2030)
9.4 Asia Isocitrate Dehydrogenase Inhibitors Market Size by Region
9.4.1 Asia Isocitrate Dehydrogenase Inhibitors Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Isocitrate Dehydrogenase Inhibitors Market Size by Region (2019-2024)
9.4.3 Asia Isocitrate Dehydrogenase Inhibitors Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Isocitrate Dehydrogenase Inhibitors Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Type
10.2.1 Middle East, Africa, and Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Isocitrate Dehydrogenase Inhibitors Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Application
10.3.1 Middle East, Africa, and Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Isocitrate Dehydrogenase Inhibitors Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Country
10.4.1 Middle East, Africa, and Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 AGIOS
11.1.1 AGIOS Company Details
11.1.2 AGIOS Business Overview
11.1.3 AGIOS Isocitrate Dehydrogenase Inhibitors Introduction
11.1.4 AGIOS Revenue in Isocitrate Dehydrogenase Inhibitors Business (2019-2024)
11.1.5 AGIOS Recent Developments
11.2 Aslan Pharmaceuticals
11.2.1 Aslan Pharmaceuticals Company Details
11.2.2 Aslan Pharmaceuticals Business Overview
11.2.3 Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Introduction
11.2.4 Aslan Pharmaceuticals Revenue in Isocitrate Dehydrogenase Inhibitors Business (2019-2024)
11.2.5 Aslan Pharmaceuticals Recent Developments
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Isocitrate Dehydrogenase Inhibitors Introduction
11.3.4 Bayer Revenue in Isocitrate Dehydrogenase Inhibitors Business (2019-2024)
11.3.5 Bayer Recent Developments
11.4 Beigene
11.4.1 Beigene Company Details
11.4.2 Beigene Business Overview
11.4.3 Beigene Isocitrate Dehydrogenase Inhibitors Introduction
11.4.4 Beigene Revenue in Isocitrate Dehydrogenase Inhibitors Business (2019-2024)
11.4.5 Beigene Recent Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Introduction
11.5.4 Bristol-Myers Squibb Revenue in Isocitrate Dehydrogenase Inhibitors Business (2019-2024)
11.5.5 Bristol-Myers Squibb Recent Developments
11.6 Celgene
11.6.1 Celgene Company Details
11.6.2 Celgene Business Overview
11.6.3 Celgene Isocitrate Dehydrogenase Inhibitors Introduction
11.6.4 Celgene Revenue in Isocitrate Dehydrogenase Inhibitors Business (2019-2024)
11.6.5 Celgene Recent Developments
11.7 Daiichi Sankyo
11.7.1 Daiichi Sankyo Company Details
11.7.2 Daiichi Sankyo Business Overview
11.7.3 Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Introduction
11.7.4 Daiichi Sankyo Revenue in Isocitrate Dehydrogenase Inhibitors Business (2019-2024)
11.7.5 Daiichi Sankyo Recent Developments
11.8 Philogen S.p.A.
11.8.1 Philogen S.p.A. Company Details
11.8.2 Philogen S.p.A. Business Overview
11.8.3 Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Introduction
11.8.4 Philogen S.p.A. Revenue in Isocitrate Dehydrogenase Inhibitors Business (2019-2024)
11.8.5 Philogen S.p.A. Recent Developments
11.9 Tesaro
11.9.1 Tesaro Company Details
11.9.2 Tesaro Business Overview
11.9.3 Tesaro Isocitrate Dehydrogenase Inhibitors Introduction
11.9.4 Tesaro Revenue in Isocitrate Dehydrogenase Inhibitors Business (2019-2024)
11.9.5 Tesaro Recent Developments
11.10 Tragara/Adastra
11.10.1 Tragara/Adastra Company Details
11.10.2 Tragara/Adastra Business Overview
11.10.3 Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Introduction
11.10.4 Tragara/Adastra Revenue in Isocitrate Dehydrogenase Inhibitors Business (2019-2024)
11.10.5 Tragara/Adastra Recent Developments
11.11 Tocagen
11.11.1 Tocagen Company Details
11.11.2 Tocagen Business Overview
11.11.3 Tocagen Isocitrate Dehydrogenase Inhibitors Introduction
11.11.4 Tocagen Revenue in Isocitrate Dehydrogenase Inhibitors Business (2019-2024)
11.11.5 Tocagen Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Agios
Aslan Pharmaceuticals
Bayer
BeiGene Ltd
Bristol–Myers Squibb
Celgene
Daiichi Sankyo
Philogen
Tesaro
Tragara/Adastra
Tocagen
List of Tables
    Table 1. Global Isocitrate Dehydrogenase Inhibitors Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of IDH1 Mutant Medullary Malignant Tumor
    Table 3. Key Players of IDH2 Mutant Medullary Malignant Tumor
    Table 4. Key Players of Others
    Table 5. Global Isocitrate Dehydrogenase Inhibitors Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Isocitrate Dehydrogenase Inhibitors Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Isocitrate Dehydrogenase Inhibitors Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Isocitrate Dehydrogenase Inhibitors Market Share by Region (2019-2024)
    Table 9. Global Isocitrate Dehydrogenase Inhibitors Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Isocitrate Dehydrogenase Inhibitors Market Share by Region (2025-2030)
    Table 11. Isocitrate Dehydrogenase Inhibitors Market Trends
    Table 12. Isocitrate Dehydrogenase Inhibitors Market Drivers
    Table 13. Isocitrate Dehydrogenase Inhibitors Market Challenges
    Table 14. Isocitrate Dehydrogenase Inhibitors Market Restraints
    Table 15. Global Isocitrate Dehydrogenase Inhibitors Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Isocitrate Dehydrogenase Inhibitors Revenue Share by Players (2019-2024)
    Table 17. Global Top Isocitrate Dehydrogenase Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Isocitrate Dehydrogenase Inhibitors as of 2023)
    Table 18. Global Isocitrate Dehydrogenase Inhibitors Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Isocitrate Dehydrogenase Inhibitors Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Isocitrate Dehydrogenase Inhibitors, Headquarters and Area Served
    Table 21. Global Key Players of Isocitrate Dehydrogenase Inhibitors, Product and Application
    Table 22. Global Key Players of Isocitrate Dehydrogenase Inhibitors, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Isocitrate Dehydrogenase Inhibitors Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Type (2019-2024)
    Table 26. Global Isocitrate Dehydrogenase Inhibitors Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Type (2025-2030)
    Table 28. Global Isocitrate Dehydrogenase Inhibitors Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Isocitrate Dehydrogenase Inhibitors Revenue Share by Application (2019-2024)
    Table 30. Global Isocitrate Dehydrogenase Inhibitors Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Isocitrate Dehydrogenase Inhibitors Revenue Share by Application (2025-2030)
    Table 32. North America Isocitrate Dehydrogenase Inhibitors Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Isocitrate Dehydrogenase Inhibitors Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Isocitrate Dehydrogenase Inhibitors Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Isocitrate Dehydrogenase Inhibitors Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Isocitrate Dehydrogenase Inhibitors Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Isocitrate Dehydrogenase Inhibitors Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Isocitrate Dehydrogenase Inhibitors Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Isocitrate Dehydrogenase Inhibitors Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Isocitrate Dehydrogenase Inhibitors Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Isocitrate Dehydrogenase Inhibitors Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Isocitrate Dehydrogenase Inhibitors Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Isocitrate Dehydrogenase Inhibitors Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Isocitrate Dehydrogenase Inhibitors Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Isocitrate Dehydrogenase Inhibitors Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Isocitrate Dehydrogenase Inhibitors Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Isocitrate Dehydrogenase Inhibitors Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Isocitrate Dehydrogenase Inhibitors Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Isocitrate Dehydrogenase Inhibitors Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Isocitrate Dehydrogenase Inhibitors Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Isocitrate Dehydrogenase Inhibitors Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Isocitrate Dehydrogenase Inhibitors Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Isocitrate Dehydrogenase Inhibitors Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Isocitrate Dehydrogenase Inhibitors Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Isocitrate Dehydrogenase Inhibitors Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Isocitrate Dehydrogenase Inhibitors Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Isocitrate Dehydrogenase Inhibitors Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Country (2025-2030) & (US$ Million)
    Table 64. AGIOS Company Details
    Table 65. AGIOS Business Overview
    Table 66. AGIOS Isocitrate Dehydrogenase Inhibitors Product
    Table 67. AGIOS Revenue in Isocitrate Dehydrogenase Inhibitors Business (2019-2024) & (US$ Million)
    Table 68. AGIOS Recent Developments
    Table 69. Aslan Pharmaceuticals Company Details
    Table 70. Aslan Pharmaceuticals Business Overview
    Table 71. Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Product
    Table 72. Aslan Pharmaceuticals Revenue in Isocitrate Dehydrogenase Inhibitors Business (2019-2024) & (US$ Million)
    Table 73. Aslan Pharmaceuticals Recent Developments
    Table 74. Bayer Company Details
    Table 75. Bayer Business Overview
    Table 76. Bayer Isocitrate Dehydrogenase Inhibitors Product
    Table 77. Bayer Revenue in Isocitrate Dehydrogenase Inhibitors Business (2019-2024) & (US$ Million)
    Table 78. Bayer Recent Developments
    Table 79. Beigene Company Details
    Table 80. Beigene Business Overview
    Table 81. Beigene Isocitrate Dehydrogenase Inhibitors Product
    Table 82. Beigene Revenue in Isocitrate Dehydrogenase Inhibitors Business (2019-2024) & (US$ Million)
    Table 83. Beigene Recent Developments
    Table 84. Bristol-Myers Squibb Company Details
    Table 85. Bristol-Myers Squibb Business Overview
    Table 86. Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Product
    Table 87. Bristol-Myers Squibb Revenue in Isocitrate Dehydrogenase Inhibitors Business (2019-2024) & (US$ Million)
    Table 88. Bristol-Myers Squibb Recent Developments
    Table 89. Celgene Company Details
    Table 90. Celgene Business Overview
    Table 91. Celgene Isocitrate Dehydrogenase Inhibitors Product
    Table 92. Celgene Revenue in Isocitrate Dehydrogenase Inhibitors Business (2019-2024) & (US$ Million)
    Table 93. Celgene Recent Developments
    Table 94. Daiichi Sankyo Company Details
    Table 95. Daiichi Sankyo Business Overview
    Table 96. Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Product
    Table 97. Daiichi Sankyo Revenue in Isocitrate Dehydrogenase Inhibitors Business (2019-2024) & (US$ Million)
    Table 98. Daiichi Sankyo Recent Developments
    Table 99. Philogen S.p.A. Company Details
    Table 100. Philogen S.p.A. Business Overview
    Table 101. Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Product
    Table 102. Philogen S.p.A. Revenue in Isocitrate Dehydrogenase Inhibitors Business (2019-2024) & (US$ Million)
    Table 103. Philogen S.p.A. Recent Developments
    Table 104. Tesaro Company Details
    Table 105. Tesaro Business Overview
    Table 106. Tesaro Isocitrate Dehydrogenase Inhibitors Product
    Table 107. Tesaro Revenue in Isocitrate Dehydrogenase Inhibitors Business (2019-2024) & (US$ Million)
    Table 108. Tesaro Recent Developments
    Table 109. Tragara/Adastra Company Details
    Table 110. Tragara/Adastra Business Overview
    Table 111. Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Product
    Table 112. Tragara/Adastra Revenue in Isocitrate Dehydrogenase Inhibitors Business (2019-2024) & (US$ Million)
    Table 113. Tragara/Adastra Recent Developments
    Table 114. Tocagen Company Details
    Table 115. Tocagen Business Overview
    Table 116. Tocagen Isocitrate Dehydrogenase Inhibitors Product
    Table 117. Tocagen Revenue in Isocitrate Dehydrogenase Inhibitors Business (2019-2024) & (US$ Million)
    Table 118. Tocagen Recent Developments
    Table 119. Research Programs/Design for This Report
    Table 120. Key Data Information from Secondary Sources
    Table 121. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Isocitrate Dehydrogenase Inhibitors Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Isocitrate Dehydrogenase Inhibitors Market Share by Type: 2023 VS 2030
    Figure 3. IDH1 Mutant Medullary Malignant Tumor Features
    Figure 4. IDH2 Mutant Medullary Malignant Tumor Features
    Figure 5. Others Features
    Figure 6. Global Isocitrate Dehydrogenase Inhibitors Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Isocitrate Dehydrogenase Inhibitors Market Share by Application: 2023 VS 2030
    Figure 8. DH Inhibitor Case Studies
    Figure 9. FLT3 Inhibitor Case Studies
    Figure 10. Hedgehog Pathway Inhibitor Case Studies
    Figure 11. Others Case Studies
    Figure 12. Isocitrate Dehydrogenase Inhibitors Report Years Considered
    Figure 13. Global Isocitrate Dehydrogenase Inhibitors Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Isocitrate Dehydrogenase Inhibitors Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Isocitrate Dehydrogenase Inhibitors Market Share by Region: 2023 VS 2030
    Figure 16. Global Isocitrate Dehydrogenase Inhibitors Market Share by Players in 2023
    Figure 17. Global Top Isocitrate Dehydrogenase Inhibitors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Isocitrate Dehydrogenase Inhibitors as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Isocitrate Dehydrogenase Inhibitors Revenue in 2023
    Figure 19. North America Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Isocitrate Dehydrogenase Inhibitors Market Share by Type (2019-2030)
    Figure 21. North America Isocitrate Dehydrogenase Inhibitors Market Share by Application (2019-2030)
    Figure 22. North America Isocitrate Dehydrogenase Inhibitors Market Share by Country (2019-2030)
    Figure 23. United States Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Isocitrate Dehydrogenase Inhibitors Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Isocitrate Dehydrogenase Inhibitors Market Share by Type (2019-2030)
    Figure 27. Europe Isocitrate Dehydrogenase Inhibitors Market Share by Application (2019-2030)
    Figure 28. Europe Isocitrate Dehydrogenase Inhibitors Market Share by Country (2019-2030)
    Figure 29. Germany Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Isocitrate Dehydrogenase Inhibitors Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Isocitrate Dehydrogenase Inhibitors Market Share by Type (2019-2030)
    Figure 37. China Isocitrate Dehydrogenase Inhibitors Market Share by Application (2019-2030)
    Figure 38. Asia Isocitrate Dehydrogenase Inhibitors Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Isocitrate Dehydrogenase Inhibitors Market Share by Type (2019-2030)
    Figure 40. Asia Isocitrate Dehydrogenase Inhibitors Market Share by Application (2019-2030)
    Figure 41. Asia Isocitrate Dehydrogenase Inhibitors Market Share by Region (2019-2030)
    Figure 42. Japan Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Isocitrate Dehydrogenase Inhibitors Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Isocitrate Dehydrogenase Inhibitors Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Isocitrate Dehydrogenase Inhibitors Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Isocitrate Dehydrogenase Inhibitors Market Share by Country (2019-2030)
    Figure 52. Brazil Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. AGIOS Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2019-2024)
    Figure 59. Aslan Pharmaceuticals Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2019-2024)
    Figure 60. Bayer Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2019-2024)
    Figure 61. Beigene Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2019-2024)
    Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2019-2024)
    Figure 63. Celgene Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2019-2024)
    Figure 64. Daiichi Sankyo Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2019-2024)
    Figure 65. Philogen S.p.A. Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2019-2024)
    Figure 66. Tesaro Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2019-2024)
    Figure 67. Tragara/Adastra Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2019-2024)
    Figure 68. Tocagen Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2019-2024)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Isocitrate Dehydrogenase IDH Inhibitors Market Research Report 2024
Global Iminodiacetic Acid IDA Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Succinate Dehydrogenase Inhibitor SDHI Market Research Report 2025
Global Hydroxycitric Acid HCA Market Insights Forecast to 2030
Isocitric Acid Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Indoximod Market Research Report 2024
Global Di isononyl cyclohexane 1 2 dicarboxylate DINCH Market Insights Forecast to 2030
Global GAPDH Antibody Market Research Report 2024
Global IDO Inhibitor Market Research Report 2024
Global 1 3 Diiodo 5 5 dimethyl hydantoin DIH Market Research Report 2024
Antidiuretic Hormone ADH Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Idhifa Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dihydrowhey Dehydrogenase DHODH Inhibitor Market Research Report 2024
Global Isocitrate Lyase ICL Activity Assay Kit Market Research Report 2024
Ivosidenib Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ivosidenib Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Alpha Ketoglutaric Acid Market Insights Forecast to 2030
11 Cis Retinol Dehydrogenase RDH5 Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Indoleamine 2 3 Dioxygenase 1 IDO1 Antibody Market Research Report 2024
Global Maltase Dehydrogenase Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions